Our strong pipeline—one of the most robust in the industry—includes biologics, small molecules, immunotherapies, and biosimilars, and is centered on exploring a ...

Explore the Product Pipeline. Take a deep dive into the investigational medicines and vaccines we're working on. Updated as of October 29, 2024.

10 мар. 2024 г. · That $43 billion Seagen acquisition doubled Pfizer's oncology drug pipeline to 60 different experimental programs. ... Pfizer's mid-stage oncology ...

30 сент. 2024 г. · Pfizer's ponsegromab saw a 16-point increase in its Phase Transition Success Rate (PTSR), settling at 42% in cancer cachexia or cancer-related ...

29 февр. 2024 г. · The $43 billion deal doubled Pfizer's oncology pipeline to 60 programs. Now, during an innovation day Thursday, the Big Pharma is touting a ...

29 февр. 2024 г. · Pfizer aims to have at least eight blockbuster cancer drugs by 2030, with a focus on four main cancer types.

11 сент. 2024 г. · Supplementary material for Pfizer Oncology's Breast Cancer Pipeline – September 2024.

13 июн. 2024 г. · Pfizer's oncology division plans to have eight blockbusters by 2030, with contributions from each of its four focused therapeutic areas.

29 февр. 2024 г. · ADC, antibody-drug conjugate; HNSCC, head and neck squamous cell carcinoma; IO, immuno-oncology; NSCLC, non-small cell lung cancer. Bispecific.

31 окт. 2023 г. · Pfizer's new cost-saving agenda will see five pipeline programs in oncology, rare disease and immunology packed off to the graveyard.